Los Angeles Capital Management’s Allergan plc AGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q2 | – | Sell |
-2,189
| Closed | -$388K | – | 1550 |
|
|
2020
Q1 | $388K | Sell |
2,189
-2,920
| -57% | -$550K | ﹤0.01% | 983 |
|
|
2019
Q4 | $977K | Sell |
5,109
-100
| -2% | -$18K | ﹤0.01% | 847 |
|
|
2019
Q3 | $877K | Sell |
5,209
-48,808
| -90% | -$7.95M | ﹤0.01% | 841 |
|
|
2019
Q2 | $9.04M | Sell |
54,017
-64,910
| -55% | -$8.99M | 0.05% | 327 |
|
|
2019
Q1 | $17.4M | Sell |
118,927
-20,860
| -15% | -$3.02M | 0.1% | 219 |
|
|
2018
Q4 | $18.7M | Buy |
139,787
+53,249
| +62% | +$8.73M | 0.12% | 189 |
|
|
2018
Q3 | $16.5M | Buy |
86,538
+14,630
| +20% | +$2.69M | 0.09% | 254 |
|
|
2018
Q2 | $12M | Buy |
71,908
+69,429
| +2,801% | +$11.1M | 0.07% | 318 |
|
|
2018
Q1 | $417K | Sell |
2,479
-4,265
| -63% | -$715K | ﹤0.01% | 1086 |
|
|
2017
Q4 | $1.1M | Sell |
6,744
-227,144
| -97% | -$40.8M | 0.01% | 834 |
|
|
2017
Q3 | $47.9M | Sell |
233,888
-99,296
| -30% | -$23.1M | 0.28% | 99 |
|
|
2017
Q2 | $81M | Buy |
333,184
+51,725
| +18% | +$12.2M | 0.51% | 35 |
|
|
2017
Q1 | $67.2M | Buy |
281,459
+196,576
| +232% | +$45.8M | 0.49% | 39 |
|
|
2016
Q4 | $17.8M | Sell |
84,883
-1,441
| -2% | -$299K | 0.14% | 195 |
|
|
2016
Q3 | $19.9M | Buy |
86,324
+82,452
| +2,129% | +$20.1M | 0.17% | 172 |
|
|
2016
Q2 | $895K | Buy |
3,872
+90
| +2% | +$20.8K | 0.01% | 734 |
|
|
2016
Q1 | $1.01M | Sell |
3,782
-57,936
| -94% | -$16.6M | 0.01% | 620 |
|
|
2015
Q4 | $19.3M | Sell |
61,718
-6,021
| -9% | -$1.79M | 0.18% | 154 |
|
|
2015
Q3 | $18.4M | Buy |
67,739
+20,904
| +45% | +$6.42M | 0.18% | 157 |
|
|
2015
Q2 | $14.2M | Buy |
46,835
+42,760
| +1,049% | +$12.8M | 0.13% | 215 |
|
|
2015
Q1 | $1.21M | Buy |
4,075
+1,086
| +36% | +$310K | 0.01% | 700 |
|
|
2014
Q4 | $769K | Hold |
2,989
| – | – | 0.01% | 713 |
|
|
2014
Q3 | $721K | Buy |
2,989
+1,006
| +51% | +$225K | 0.01% | 680 |
|
|
2014
Q2 | $442K | Sell |
1,983
-55,960
| -97% | -$11.6M | ﹤0.01% | 922 |
|
|
2014
Q1 | $11.9M | Buy |
57,943
+2,291
| +4% | +$454K | 0.13% | 207 |
|
|
2013
Q4 | $9.35M | Buy |
55,652
+45,742
| +462% | +$7.15M | 0.1% | 245 |
|
|
2013
Q3 | $1.43M | Buy |
9,910
+3,590
| +57% | +$478K | 0.02% | 562 |
|
|
2013
Q2 | $798K | Buy |
+6,320
| New | +$716K | 0.01% | 736 |
|
Other funds holding AGN
AJ
C
B
JJ
VFA
OPS
Los Angeles Capital Management's AGN Position: Q2 2020 in Review
Los Angeles Capital Management sold out of Allergan plc (AGN) in Q2 2020, closing a stake of 2,189 shares — an estimated $388K sold.
Los Angeles Capital Management first reported a position in AGN in Q2 2013 and held it in 28 quarters. The position peaked at $81M in Q2 2017. 7 funds tracked by Wall St. Rank hold AGN as of Q2 2020.
- Los Angeles Capital Management reported no remaining Allergan plc position as of Q2 2020 after selling out during the quarter.
- Los Angeles Capital Management sold 2,189 Allergan plc shares in Q2 2020, an estimated $388K.
- Los Angeles Capital Management first reported a position in Allergan plc in Q2 2013 and held it in 28 quarters.
- Los Angeles Capital Management's Allergan plc position peaked at $81M in Q2 2017.
- 7 funds tracked by Wall St. Rank held Allergan plc as of Q2 2020.
Based on Los Angeles Capital Management's 13F filing for Q2 2020, filed 5 Aug 2020.